JPS60123419A - 製薬組成物 - Google Patents

製薬組成物

Info

Publication number
JPS60123419A
JPS60123419A JP59242550A JP24255084A JPS60123419A JP S60123419 A JPS60123419 A JP S60123419A JP 59242550 A JP59242550 A JP 59242550A JP 24255084 A JP24255084 A JP 24255084A JP S60123419 A JPS60123419 A JP S60123419A
Authority
JP
Japan
Prior art keywords
solvent
salt
nitroxynil
glycofurol
levamisole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59242550A
Other languages
English (en)
Japanese (ja)
Inventor
マリア・ロジナ・クラーク
アンドルー・ルイス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Publication of JPS60123419A publication Critical patent/JPS60123419A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP59242550A 1983-11-21 1984-11-19 製薬組成物 Pending JPS60123419A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838331037A GB8331037D0 (en) 1983-11-21 1983-11-21 Compositions of matter
GB8331037 1983-11-21

Publications (1)

Publication Number Publication Date
JPS60123419A true JPS60123419A (ja) 1985-07-02

Family

ID=10552109

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59242550A Pending JPS60123419A (ja) 1983-11-21 1984-11-19 製薬組成物

Country Status (15)

Country Link
JP (1) JPS60123419A (es)
AU (1) AU3564984A (es)
BE (1) BE901095A (es)
CA (1) CA1236402A (es)
CH (1) CH662273A5 (es)
DE (1) DE3442402A1 (es)
DK (1) DK548884A (es)
ES (1) ES8600933A1 (es)
FR (1) FR2555047B1 (es)
GB (2) GB8331037D0 (es)
HU (1) HU196307B (es)
IT (1) IT1177262B (es)
NL (1) NL8403528A (es)
NZ (1) NZ210247A (es)
ZA (1) ZA849008B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014506249A (ja) * 2010-12-27 2014-03-13 インターベツト・インターナシヨナル・ベー・ベー グリコフロールを含む経表面局所イソオキサゾリン製剤

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0147883A3 (en) * 1983-12-21 1986-12-30 Janssen Pharmaceutica N.V. Aqueous non-aggressive anthelmintic pour-on formulations
AU5733986A (en) * 1985-05-13 1986-11-20 Syntex (U.S.A.) Inc. Anthelmintic compositions comprising a benzimidazole derivative and the fasciolicide rafoxanide
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica
BRPI0506279B1 (pt) 2005-12-16 2018-01-09 Npa - Núcleo De Pesquisas Aplicadas Ltda Composição sinergística de antihelmínticos e endectocidas
CN100500648C (zh) * 2006-12-29 2009-06-17 浙江工业大学 一种硝碘酚腈的合成方法
BRPI0904365A2 (pt) * 2009-11-05 2011-11-16 Ouro Fino Participacoes E Empreendimentos S A associações farmacêuticas, composições farmacêuticas, medicamento e método para o tratamento de animais

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
AU527154B2 (en) * 1978-12-15 1983-02-17 Pitman-Moore Australia Limited Composition and process
DE3163536D1 (en) * 1980-11-20 1984-06-14 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
NZ202422A (en) * 1981-11-25 1985-02-28 Ici Australia Ltd D, l-and l-2,3,5,6-tetrahydro-6-phenylimidazo(2,1-b)thiazolium 4-cyano-2-iodo-6-nitrophenoxide and veterinary compositions

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014506249A (ja) * 2010-12-27 2014-03-13 インターベツト・インターナシヨナル・ベー・ベー グリコフロールを含む経表面局所イソオキサゾリン製剤
JP2016216489A (ja) * 2010-12-27 2016-12-22 インターベット インターナショナル ベー． フェー． グリコフロールを含む経表面局所イソオキサゾリン製剤
JP2018154657A (ja) * 2010-12-27 2018-10-04 インターベット インターナショナル ベー． フェー． グリコフロールを含む経表面局所イソオキサゾリン製剤

Also Published As

Publication number Publication date
AU3564984A (en) 1985-05-30
GB2150024A (en) 1985-06-26
ES537825A0 (es) 1985-10-16
NL8403528A (nl) 1985-06-17
ZA849008B (en) 1985-07-31
GB8429264D0 (en) 1984-12-27
FR2555047A1 (fr) 1985-05-24
BE901095A (fr) 1985-05-20
IT8423660A0 (it) 1984-11-20
ES8600933A1 (es) 1985-10-16
IT1177262B (it) 1987-08-26
CA1236402A (en) 1988-05-10
CH662273A5 (fr) 1987-09-30
NZ210247A (en) 1988-01-08
DK548884A (da) 1985-05-22
DK548884D0 (da) 1984-11-19
HU196307B (en) 1988-11-28
FR2555047B1 (fr) 1987-04-17
HUT35955A (en) 1985-08-28
GB2150024B (en) 1987-02-04
DE3442402A1 (de) 1985-05-30
GB8331037D0 (en) 1983-12-29
IT8423660A1 (it) 1986-05-20

Similar Documents

Publication Publication Date Title
SK10095A3 (en) Injection and injection kit containing omeprazole and its analogs
KR100785603B1 (ko) 치환된 벤즈이미다졸의 제제
JP2021519817A (ja) 液体薬学的製剤
KR20070026187A (ko) 2개 이상의 활성 물질을 함유하는 주사용 멸균 약제학적제형
JPH01502022A (ja) 駆虫薬第４級アルキルアシルヒドラゾン、使用方法および組成物
JPS60123419A (ja) 製薬組成物
JP2020525516A (ja) 注射用組成物
DE1470105A1 (de) Substituierte Benzimidazole und Verfahren zu deren Herstellung
CS235997B2 (en) Method of 1-(3-methyl-4-trifluormethylthiophenoxy)fenyl)-3-methyl-1,3,5-triazine-2,4,6-(1h,3h,5h)-trion solutions production
EP0415889A2 (de) Anthelmintika
US4076824A (en) Anthelmintic oxadiazolinone derivatives
IE48607B1 (en) Medicinal formulation
US4618618A (en) Compounds and compositions
US3538108A (en) Water - soluble 2 - substituted benzimidazole methanesulfonic acid salts
DE2016622A1 (en) Anthelmintic benzimidazole deriv
NO750172L (es)
EP0105029A2 (de) Barbitursäurederivate als Anthelmintika
BRPI0505716B1 (pt) sal orgânico de levamisol, processo de preparação do mesmo, composição farmacêutica e seu uso no combate de helmintiases
US3928437A (en) Phenoxy-phenyl, phenylthiophenyl, phenylsulfonylphenyl and phenylaminophenyl diaminothioureas
RU2348610C2 (ru) Средство, представляющее собой 2-(4'-хлорфенокси)-n, n-диэтилэтанамина гидрохлорид, обладающее прямым антикоагулянтным действием
DE2325036A1 (de) Arylenverbindungen
EP0010242A1 (de) 2-Benzimidazolylcarbamidsäureester, diese enthaltende Arzneimittel sowie Verfahren zur ihrer Herstellung
IE48608B1 (en) Medicinal formulation
US3968209A (en) Anthelmintic use of phosphorylated thioureas
DE2630847A1 (de) Methoxycarbonyl-phenyl-guanidine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel